OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Naxitamab Activity in Neuroblastoma Cells Is Enhanced by Nanofenretinide and Nanospermidine
Lucrezia Galassi, Martina Rossi, Pietro Lodeserto, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 648-648
Open Access | Times Cited: 7
Lucrezia Galassi, Martina Rossi, Pietro Lodeserto, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 648-648
Open Access | Times Cited: 7
Showing 7 citing articles:
Biology of GD2 ganglioside: implications for cancer immunotherapy
Pierre Machy, Erwan Mortier, Stéphane Birklé
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 24
Pierre Machy, Erwan Mortier, Stéphane Birklé
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 24
Highly anticipated natural diterpenoids as an important source of new drugs in 2013–2023
Yingjie Wang, Peng Tang, Wen‐Chao Tu, et al.
Chinese Chemical Letters (2024) Vol. 36, Iss. 1, pp. 109955-109955
Closed Access | Times Cited: 6
Yingjie Wang, Peng Tang, Wen‐Chao Tu, et al.
Chinese Chemical Letters (2024) Vol. 36, Iss. 1, pp. 109955-109955
Closed Access | Times Cited: 6
Emerging clinical and research approaches in targeted therapies for high-risk neuroblastoma
Albatool AlKhazal, Saibah Chohan, David J. Ross, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Albatool AlKhazal, Saibah Chohan, David J. Ross, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Nano-fenretinide demonstrates remarkable activity in acute promyeloid leukemia cells
Giovanna Farruggia, Lorenzo Anconelli, Lucrezia Galassi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Giovanna Farruggia, Lorenzo Anconelli, Lucrezia Galassi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Neuroblastoma—A Review of Combination Immunotherapy
Barbara Pieniążek, Katarzyna Cencelewicz, Patrycja Bździuch, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7730-7730
Open Access | Times Cited: 1
Barbara Pieniążek, Katarzyna Cencelewicz, Patrycja Bździuch, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7730-7730
Open Access | Times Cited: 1
Immunotherapy Options for Neuroblastoma: What is on the Horizon?
Aysima Karakus, Beyda Berberogullari
Current Molecular Biology Reports (2024) Vol. 10, Iss. 3, pp. 43-53
Closed Access
Aysima Karakus, Beyda Berberogullari
Current Molecular Biology Reports (2024) Vol. 10, Iss. 3, pp. 43-53
Closed Access
Antiproliferative and Morphological Effects of Fenretinide Lipid Nanosystems in Colon Adenocarcinoma Cells
Lorenzo Anconelli, Francesca Farioli, Pietro Lodeserto, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1421-1421
Open Access
Lorenzo Anconelli, Francesca Farioli, Pietro Lodeserto, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1421-1421
Open Access
